Zymeworks (NYSE: ZYME) reported Q4 EPS of ($0.95), $0.22 better than the analyst estimate of ($1.17). Revenue for the quarter came in at $19.87 million versus the consensus estimate of $9.13 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.